

![]() |
Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study |
|
Authors | ![]() | |
Published in | Neurology. 2013, vol. 80, no. 6, p. 553-60 | |
Abstract | To assess the efficacy and safety of rivastigmine for the treatment of HIV-associated neurocognitive disorders (HAND) in a cohort of long-lasting aviremic HIV+ patients. | |
Keywords | AIDS Dementia Complex/drug therapy — Cross-Over Studies — Double-Blind Method — Executive Function/drug effects — Female — Humans — Male — Middle Aged — Neuroprotective Agents/therapeutic use — Neuropsychological Tests — Phenylcarbamates/therapeutic use — Pilot Projects | |
Identifiers | PMID: 23345635 | |
Full text | ||
Structures | ||
Research group | VIH/SIDA (930) | |
Citation (ISO format) | SIMIONI, Samanta et al. Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study. In: Neurology, 2013, vol. 80, n° 6, p. 553-60. doi: 10.1212/WNL.0b013e3182815497 https://archive-ouverte.unige.ch/unige:33912 |